Zura Bio Limited

Last updated September 27, 2026

Organization details

Legal name
Zura Bio Limited
Ownership
Public
Status
Active
Headquarters country
Cayman Islands
Ticker symbol
ZURA
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001855644

Board of directors

Chief executives

Someit Sidhu · Chief Executive Officer
Dates unknown
Robert Lisicki · Chief Executive Officer
Dates unknown
Sandeep Chidambar Kulkarni · Chief Executive Officer
Dates unknown

Board connections

7 of this board's directors also sit on 12 other boards.

Network of Zura Bio Limited's board connections Damora Therapeutics Inc. Damora Therapeutics In... Amanat Acquisition Corp Amanat Acquisition Cor... Arcus Biosciences Inc. Arcus Biosciences Inc. Arcutis Biotherapeutics Inc. Arcutis Biotherapeutic... Avalo Therapeutics Inc. Avalo Therapeutics Inc... Cadrenal Therapeutics Inc. Cadrenal Therapeutics... Celldex Therapeutics Inc. Celldex Therapeutics I... Inhibikase Therapeutics Inc. Inhibikase Therapeutic... JATT II Acquisition Corp JATT II Acquisition Co... Jade Biosciences Inc. Jade Biosciences Inc. Sagimet Biosciences Inc. Sagimet Biosciences In... Syndax Pharmaceuticals Inc. Syndax Pharmaceuticals... Amit Munshi Amit Munshi Garry Arthur Neil Garry Arthur Neil Jennifer Jarrett Jennifer Jarrett Mark Eisner Mark Eisner Robert Lisicki Robert Lisicki Sandeep Chidambar Kulkarni Sandeep Chidambar Ku... Someit Sidhu Someit Sidhu Zura Bio Limited
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$12,500,000
1 purchase by 1 insider
Sold, last 12 months
$0
0 sales by 0 insiders
Date Insider Transaction Shares Price Value
Feb 26, 2026 Access Industries Holdings LLC 10% owner Open-market purchase +2,000,000 $6.25 $12,500,000
Nov 25, 2024 Parvinder Thiara Director Open-market sale −1,001,633 $2.73 $2,734,458
Sep 16, 2024 Davis Kim Officer (Chief Legal Officer) Grant or award +1,000 — —
Sep 11, 2024 Parvinder Thiara Director Open-market sale −3,800,000 $2.70 $10,260,000
Sep 4, 2024 Someit Sidhu Director Open-market sale −51,728 $3.87 $200,187
Sep 4, 2024 Someit Sidhu Director Other −593,055 — —
Aug 24, 2024 Someit Sidhu Director Grant or award +835,110 — —
Aug 24, 2024 Someit Sidhu Director Grant or award +721,971 — —
Aug 23, 2024 Badial Verender S. Officer (Chief Financial Officer) Grant or award +126,155 — —
May 18, 2024 Howell Michael Officer (See Remarks) Shares withheld for tax −9,860 $6.05 $59,653
May 17, 2024 Van Amstel Arnout Ploos Director Open-market purchase +80,000 $6.20 $496,000
Apr 22, 2024 Howell Michael Officer (See Remarks) Open-market purchase +7,987 $3.13 $24,999
Apr 22, 2024 Nistala Kiran Officer (Executive Vice President) Open-market purchase +3,195 $3.13 $10,000
Apr 22, 2024 Amit Munshi Director Open-market purchase +159,744 $3.13 $499,999
Apr 22, 2024 Someit Sidhu Director Open-market purchase +1,186,901 $3.13 $3,715,000

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.